Agarwal Arjun Insider Trades & Stock Holdings
Agarwal Arjun, Senior Vice President, Finance at Oruka Therapeutics, Inc. has 2 Form 4 trades on file since Sep 21, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($856.92K), net -$856.92K. Latest filing: disposed of 10K shares of $ORKA on Oct 12, 2026 at $80.60.
- Trades on file
- 2
- Open-market bought
- $0
- Open-market sold
- $856.92K
- Net open-market
- -$856.92K
- Latest filing
- Oct 12, 2026
All insider trades by Agarwal Arjun
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ORKA | Sell (Open-market sale) 10b5-1 | 10K | $80.60 | $805.89K | Senior Vice President, Finance | Read | |||||||
| $ORKA | Sell (Open-market sale) 10b5-1 | 533 | $95.75 | $51.03K | -9.8% | Senior Vice President, Finance | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Agarwal Arjun traded
Frequently asked questions
Has Agarwal Arjun been buying or selling stock?
Agarwal Arjun has 0 open-market purchases and 2 open-market sales on file, net -$856.92K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Agarwal Arjun's latest insider trade?
disposed of 10K shares of $ORKA on Oct 12, 2026 at $80.60.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.